department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Prezista · pharmadog

pharmadog
drugs
Prezista

drug

patient view →

darunavir

Marketedupdated 2mo ago

by Janssen Therapeutics

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Prezista

generic

darunavir

indication

Human Immunodeficiency Virus (HIV) Infections (AIDS)

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 26, 2026

172 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (14)

Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Jun 26, 2027patentUS 7700645*PED354d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d
Dec 26, 2026compositionUS 7700645172d

Data sources

ClinicalTrials.gov

last refreshed 43m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagApproval2 co-mentions · 1 sources
tagSmall Molecule1 co-mentions · 1 sources
drug(cobicistat + darunavir)1 co-mentions · 1 sources
drugcobicistat1 co-mentions · 1 sources
drug(cobicistat + darunavir) ODT1 co-mentions · 1 sources

Trials studying darunavir

phase3Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136completedn=225
—Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartumcompletedn=205
phase4A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participantscompletedn=8
phase1Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participantscompletedn=30
phase1A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agentscompletedn=37
phase1A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditionscompletedn=22
phase1A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participantscompletedn=126
phase1A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participantscompletedn=28

more trials →